Fibroblast growth factor 2 - A predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer

Dirk Rades, Cornelia Setter, Olav Dahl, Steven E. Schild, Frank Noack

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Purpose: The prognostic value of the tumor cell expression of the fibroblast growth factor 2 (FGF-2) in patients with non-small-cell lung cancer (NSCLC) is unclear. The present study investigated the effect of tumor cell expression of FGF-2 on the outcome of 60 patients irradiated for Stage II-III NSCLC. Methods and Materials: The effect of FGF-2 expression and 13 additional factors on locoregional control (LRC), metastasis-free survival (MFS), and overall survival (OS) were retrospectively evaluated. These additional factors included age, gender, Karnofsky performance status, histologic type, histologic grade, T and N category, American Joint Committee on Cancer stage, surgery, chemotherapy, pack-years, smoking during radiotherapy, and hemoglobin during radiotherapy. Locoregional failure was identified by endoscopy or computed tomography. Univariate analyses were performed with the Kaplan-Meier method and the Wilcoxon test and multivariate analyses with the Cox proportional hazard model. Results: On univariate analysis, improved LRC was associated with surgery (p =.017), greater hemoglobin levels (p =.036), and FGF-2 negativity (p <.001). On multivariate analysis of LRC, surgery (relative risk [RR], 2.44; p =.037), and FGF-2 expression (RR, 5.06; p <.001) maintained significance. On univariate analysis, improved MFS was associated with squamous cell carcinoma (p =.020), greater hemoglobin levels (p =.007), and FGF-2 negativity (p =.001). On multivariate analysis of MFS, the hemoglobin levels (RR, 2.65; p =.019) and FGF-2 expression (RR, 3.05; p =.004) were significant. On univariate analysis, improved OS was associated with a lower N category (p =.048), greater hemoglobin levels (p <.001), and FGF-2 negativity (p <.001). On multivariate analysis of OS, greater hemoglobin levels (RR, 4.62; p =.002) and FGF-2 expression (RR, 3.25; p =.002) maintained significance. Conclusions: Tumor cell expression of FGF-2 appeared to be an independent negative predictor of LRC, MFS, and OS.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume82
Issue number1
DOIs
StatePublished - Jan 1 2012

Keywords

  • FGF-2 expression
  • Non-small-cell lung cancer
  • fibroblast growth factor 2
  • prognostic factors
  • radiotherapy
  • treatment outcomes

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Fibroblast growth factor 2 - A predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer'. Together they form a unique fingerprint.

Cite this